VACCINES & GRAPHENE – 3. Vital! Dangerous Carbon Nanotubes as mRNA Carriers in a MODERNA Patent for COVID Spikevax
by Fabio Giuseppe Carlo Carisio
The “vexed question” on the presence of Graphene Oxide (GO) returns to sensational relevance thanks to the discovery made by an Italian computer scientist of two patents from the pharmaceutical company Moderna of Cambridge (Massachusetts), financed by Bill Gates and the military agency DARPA of the US Pentagon thanks to the supervision of the infamous American virologist Anthony Fauci.
It is not tangible and concrete proof of the presence of GO in Covid mRNA gene sera but it confirms that already in 2013 Big Pharma patented the use of carbon nanotubes in a study for the creation of a vaccine against cancer based on previous research Chinese.
Not only. That patent was cited among those on which the construction of the mRNA-1273 COVID-19 VACCINE, known by the commercial name of Spikevax, was based. These important evidentiary clues on the use of carbon derivatives such as graphene oxide accentuate the controversy on the presence of GO in Covid vaccines which is extreme in two opposing schools of thought:
- that of the mainstream which censors every hypothesis in this regard although there are countless studies on the biomedical application developed by the Graphene Flagship project financed by the European Commission, including one specific for a vaccine against SARS-Cov-2;
- and that of social media which are satisfied with dossiers circulating on the web, but not yet published by any scientific research, to support the certainty of the presence of Graphene Oxide in vaccines.
In the previous Gospa News investigations entitled “Vaccines & Graphene” we instead focused only on accredited scientific studies such as that of the Spanish chemist Pablo Campra published in 5 versions on ResearchGate in which he certified the presence of at least 8 graphenic nanoforms thanks to the electronic microscope in a vial of Pfizer-Biontech’s Covid mRNA gene serum, that of three Italian doctors corroborated by an expert report from the Electron Microscopy Laboratory of Turin University on the blood of vaccinated people, and that of an official document from the Argentine health authority reported by a magistrate, then placed under investigation for the sensational revelation.
Carbon Nanotubes and Graphene Oxide
Carbon nanotubes were discovered in 1985 by the American chemist Richard E. Smalley, who realized that, in particular situations, carbon atoms compose ordered spherical structures: fullerenes. The structure, after subsequent relaxation, tends to roll up on itself, obtaining the typical cylindrical structure. They can be seen, similarly to fullerene, as one of the allotropic forms of carbon, such as Graphene Oxide.
There are various nanotubes. Broadly speaking they can be divided into two types:
- single-walled nanotube or SWCNT (Single-Walled Carbon NanoTube): consisting of a single graphitic sheet wrapped around itself;
- multi-walled nanotube or MWCNT (Multi-Walled Carbon NanoTube): formed by multiple sheets coaxially wrapped around each other.
The body of the nanotube is made up of only hexagons, while the closing structures are made up of hexagons and pentagons, exactly like fullerenes. For this reason nanotubes can be considered as a kind of giant fullerenes. Precisely because of this conformation of hexagons and pentagons, nanotubes often have structural defects or imperfections that deform the cylinder. The diameter of an unsupported single-walled nanotube is a minimum of 0.4 nm to a maximum of 6 nm. The very high ratio between length and diameter (in the order of 104) allows them to be considered as virtually one-dimensional nanostructures and gives peculiar properties to these molecules.
This is why, although the potential danger is known and the long-term danger is unknown, Carbon Nanotubes such as those created with its allotrope Graphene Oxide have already been widely tested in the biomedical field.
Carbon nanotubes in Moderna’s 2013 patent
Now even Moderna’s patents clearly speak of Nanotubes in the point (000666), a number ominously similar to that of a Gates patent on the microchip under the skin, of the international patent WO2013151666A2 (link to the patents at the bottom of the page in the sources) filed in September 2013 by Moderna Therapeutics in which Stephane Bancel, the French researcher who is CEO of the same pharmaceutical company, is the first inventor.
Under the heading Nanotubes, on page 288 of a monumental PDF, we read the following:
“[000666] The polynucleotides, primary constructs or mmRNA of the invention can be attached or otherwise bound to at least one nanotube such as, but not limited to, rosette nanotubes, rosette nanotubes having twin bases with a linker, carbon nanotubes and/or single-walled carbon nanotubes, The polynucleotides, primary constructs or mmRNA may be bound to the nanotubes through forces such as, but not limited to, steric, ionic, covalent and/or other forces”.
The use of nanotubes is patented as a “carrier” of messenger RNA.
As we had already demonstrated in a previous investigation on Pfizer’s Covid vaccine, the real composition of the active ingredients, used to build the Lipid Nanoparticles to transport the mRNA into the human body and trigger the reaction to stimulate immunization to SARS-Cov-2, it is not completely accessible as it is covered by TradeMark (TM).
And Moderna also mentions many biochemical elements in its patents with the ambiguous ritual phrase “such as, but not limited to”…
Therefore, carbon nanomaterials such as Graphene Oxide could have been used together with the toxic lipid nanoparticles. This is confirmed by a study signed by virologist Ilaria Capua on SARS-Cov-2 financed by the European Commission, published in summer 2020 before the appearance of the Covid mRNA vaccines and even awarded globally.
But this is also confirmed by another research carried out with the same European Graphene Flagship fund to build a “project immunity”, which however foundered in failure due to the deadly tumors recorded in laboratory mice.
Carbon Nanotubes in the Blood
The danger of biotechnology with nanotubes is highlighted by Moderna itself in its patent WO2013151666A2 updated 5 times after the start of the Covid pandemic.
“[000667] In one embodiment, the nanotube can release one or more polynucleotides, primary constructs or mmRNA into cells. The size and/or the surface structure of at least one nanotube may be altered so as to govern the interaction of the nanotubes within the body and/or to attach or bind to the polynucleotides, primary constructs or mmRNA disclosed herein. In one embodiment, the building block and/or the functional groups attached to the building block of the at least one nanotube may be altered to adjust the dimensions and/or properties of the nanotube. As a non-limiting example, the length of the nanotubes may be altered to hinder the nanotubes from passing through the holes in the walls of normal blood vessels but still small enough to pass through the larger holes in the blood vessels of tumor tissue”.
These sentences explain the mobility of nanoforms in the blood which can however cause the serious phenomenon of cell damage demonstrated by multiple scientific studies on the use of Graphene Oxide in the biomedical field.
In Moderna’s patent there is no “direct” allusion to Covid vaccines but there is a huge “indirect” one:
“[000670] In one embodiment, the polynucleotides, primary constructs or mmRNA may be attached to and/or otherwise bound to at least one carbon nanotube. As a non-limiting example, the polynucleotides, primary constructs or mmRNA may be bound to a linking agent and the linked agent may be bound to the carbon nanotube (See e.g., U.S. Pat No. 8,246,995; herein incorporated by reference in its entirety). The carbon nanotube may be a single-walled nanotube (See e.g., U.S. Pat No. 8,246,995; herein incorporated by reference in its entirety)”.
For quickness, let’s read the Abstract of the aforementioned patent entitled “Hydrophobic nanotubes and nanoparticles as carriers for the release of drugs in cells” registered by Leland Stanford Junior University in which various Chinese researchers appear as inventors.
“Methods and materials for delivering biologically active molecules to cells in vitro or in vivo are provided. The methods and materials use carbon nanotubes or other hydrophobic particles, tubes and wires, functionalized with a linking group that is covalently bound to the nanotubes, or, alternatively, to the biologically active molecule, such as a protein. The biologically active molecule is preferably released from the nanotube when the complex has been taken up in an endosome”.
It should be remembered that a Chinese biomedical company patented a SARS-Cov-2 vaccine using graphene oxide but mysteriously never proposed it as a candidate for immunization against Covid.
Perhaps precisely because, as highlighted recently by Iranian researchers, this nanomaterial can be very dangerous as it can cause toxic inflammatory reactions in various human organs.
The Carbon Nanotubes mentioned in the Spikevax mRNA gene serum patent
Well, on the Moderna page where the Intellectual Property of Spikevax™ (mRNA-1273 COVID-19 VACCINE) is detailed, 11 patents are mentioned, of which US 10,703,789 is the one that is most interesting for us.
On page 131 of the document updated on 7 July 2020 (during the clinical trials of the Covid vaccine) the paragraph dedicated to “nanotubes” begins in which the entry (000666) of the previous international patent WO2013151666A2 of 2013 is repeated as is:
“The polynucleotides, primary constructs or mmRNA of the invention can be attached or otherwise bound to at least one nanotube such as, but not limited to, rosette nanotubes, rosette nanotubes having twin bases with a linker, carbon nanotubes and/or single-walled carbon nanotubes. The polynucleotides, primary constructs or mmRNA may be bound to the nanotubes through forces such as, but not limited to, steric, ionic, covalent and/or other forces”.
Then list the interconnection modes:
“In one embodiment, at least one nanotube may also be coated with delivery enhancing compounds including polymers, such as, but not limited to, polyethylene glycol. In another embodiment, at least one nanotube and/or the polynucleotides, primary constructs or mmRNA may be mixed with pharmaceutically acceptable excipients and/or delivery vehicles”.
And finally he mentions again the American patent from Leland Stanford Junior University developed by Chinese researchers:
“In one embodiment, the polynucleotides, primary constructs or mmRNA may be attached to and/or otherwise bound to at least one carbon nanotube. As a non-limiting example, the polynucleotides, primary constructs or mmRNA may be bound to a linking agent and the linked agent may be bound to the carbon nanotube (See e.g., U.S. Pat. No. 8,246,995; herein incorporated by reference in its entirety). The carbon nanotube may be a single-walled nanotube (See e.g., U.S. Pat. No. 8,246,995; herein incorporated by reference in its entirety)”.
We thank the computer scientist who, with painstaking work, managed to trace these patents and the presence of carbon nanotubes composed of graphene oxide as confirmed in the note 042 of the same patent:
The term “carbon nanotube” means a tube that contains a sheet of graphene rolled into a cylinder as small as 1 nm in diameter. Both single-walled nanotubes (SWNTs) and multiwalled nanotubes (MWNTs), with many concentric shells, have been synthesized.
Moderna’s Dangerous mRNA Gene Serums and laboratory suspicions about SARS-Cov-2
This raises disturbing questions about Moderna’s Spikevax vaccine which has already ended up in the crosshairs of multiple scientific investigations for various alarming reasons:
- recently the biochemist Robert Malone reported the awareness of Cambridge’s Big Pharma on the use of an mRNA biotechnology that has proven to be ONCOGENIC, i.e. capable of causing cancer in humans, as reported by Moderna itself in a 2019 paraflu vaccine.
Moderna AWARE that mRNA Jabs cause CANCER due to DNA Fragments. Malone Unveils Patent
- previously patent expert David. E. Martin had not only demonstrated the laboratory manipulation of coronaviruses since 2000 by Ralph Baric and Antony Fauci at the University of North Carolina but highlighted that the Spikevax COVID-19 vaccine had been patented for the first time in March 2019, i.e. 9 months before the pandemic emergency. A circumstance that should not be surprising given that the American government agency USAID and the US Department of Defense, financier of Big Pharma through the military agency DARPA, carried out a study on Covid in the bacteriological laboratories of Ukraine some months before its appearance.
- the Italian virologist Giorgio Palù with other colleagues demonstrated that 19 nucleotides of SARS-Cov-2 were incredibly identical to as many of a human gene built in the laboratory by Moderna in 2016. This led many scientists to believe that one of the first chimeric genotypes of the virus pandemic, built in the laboratory according to dozens of studies and the dossier of the US Senate Health Committee, was precisely that. Then new evidence emerged about collaborations between Chinese military medical researchers and Fauci on other similar projects.
This is why the Cambridge pharmaceutical company is among the main suspects of having caused the pandemic, with an intentional release of the virus as reported by Doctor Martin at the latest International Covid Summit conference held in the European Parliament, but also of having started a massive experiment on the human population with dangerous lipid nanoparticles and carbon nanotubes (read Graphene) as carriers of mRNA gene sera that can cause cancer.
The reason could be precisely to find a miraculous vaccine against tumors by experimenting with individual elements on unaware human guinea pigs. Added to this is also the presence of HIV sequences in the SARS-Cov-2 built in the laboratory just before the launch of Moderna’s trials for an anti-AIDS vaccine.
But in a project by the Pentagon’s DARPA military agency, as in other European projects, Graphene Oxide was also tested for its action of brain stimulation and control…
WUHAN-GATES – 52. Getting an HIV Vaccine: “May be the Real Goal behind SARS-Cov-2 Manmade”
Anyone who ignores all these details and still believes in coincidences is not only an ass of Science but is now also an established accomplice. As was Palù in part as president of the Italian Medicines Agency (AIFA) which authorized (and continues to authorise) Spikevax despite being aware of Moderna’s suspected role in the origin of the pandemic.
But the illustrious virologist from Padua, scientific disciple of Anthony Fauci and flatterer of mRNA biotechnology (in fact he is in the scientific committee of the Biotechnopolo of Siena), when he gave interviews on the subject to the mainstream media he forgot to mention American Big Pharma and aimed pointing the finger at Wuhan…
Fabio Giuseppe Carlo Carisio
© COPYRIGHT GOSPA NEWS
prohibition of reproduction without authorization
follow Fabio Carisio Gospa News director on Twitter
follow Gospa News on Telegram
MAIN SOURCES
PATENT – WO2013151666A2
PATENT – US8246995
MODERNA – INTELLECTUAL PROPERTY
PATENT– US10703789
GOSPA NEWS – VACCINES & GRAPHENE DOSSIER
https://www.gospanews.net/en/2023/12/04/fauci-before-subcommittee-on-the-covid-pandemic-to-testify-on-sars-cov-2-origin-gain-of-function-viruses-and-vaccines-mandates/
Un pensiero su “VACCINES & GRAPHENE – 3. Vital! Dangerous Carbon Nanotubes as mRNA Carriers in a MODERNA Patent for COVID Spikevax”